Case Study: Consistent assays for neurological drug development

""

A new Case Study is now available to download for free entitled ‘Improving physiological relevance in neurological disease drug development.’

In this case study, hear from Elise Malavasi, PhD, a Principal Scientist at leading contract research organisation Concept Life Sciences. The interview highlights their need to develop assays that are amenable to long-term use to support their clients with drug development, and how bit.bio’s deterministically programmed ioMicroglia have helped them develop assays with increased physiological relevance and consistency, towards this goal.

In this Case Study you will learn:

  • How Concept Life Sciences seek to develop assays proving drug candidate efficacy with human iPSC-derived microglia.
  • How ioMicroglia from bit.bio offered Concept Life Sciences functional cells with low inter-lot variability, ensuring consistent assay performance, facilitating large scale screening studies.
  • How Concept Life Science’s initial challenges integrating this new cell type into their workflows were overcome by support from the bit.bio team, ensuring they could easily develop assays using these cells.

Download ‘Improving physiological relevance in neurological disease drug development.

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free